Report cover image

Biological and Medical Imaging Reagents: Global Markets

Publisher BCC Research
Published Sep 11, 2025
Length 192 Pages
SKU # WA20408092

Description

Report Scope

The report provides an overview of the global biological and medical imaging reagent market and analyzes market trends. It includes global revenue ($ millions) using 2024 as the base year, and the forecast from 2025 through 2030. The market is segmented based on type, modality, technology, application end user, and region. The regions covered in this study include North America, Europe, Asia-Pacific, the Middle East and Africa (MEA), and South America, focusing on major countries in these regions.

The report focuses on the significant driving trends and emerging technologies that influence the market and vendor landscape. It analyzes environmental, social and corporate governance (ESG) developments and discusses patents and emerging technologies related to the market.

The report concludes with an analysis of the competitive landscape, providing the ranking/share of key global biological and medical imaging reagent companies. It also has a dedicated section of company profiles covering the profiles of leading companies in the market.

Report Includes
  • 109 data tables and 68 additional tables
  • An overview of the global market for biological and medical imaging reagents
  • Analyses of the global market trends, with data from 2022-2024, estimates for 2025, and projections of compound annual growth rates (CAGRs) through 2030
  • Evaluation of the current market size and revenue growth prospects specific to the biologic and medical imaging reagents, accompanied by a market share analysis by product type, modality, technology, application, end use, and region
  • A look at classifications, comparisons, advantages, and disadvantages of these types of diagnostic methods, and analysis of current and future demand in the global biologic and medical imaging reagents industry, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
  • A relevant patent analysis with emphasis on emerging technologies and new developments
  • A discussion on ESG challenges and practices of the industry
  • Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies
  • Company profiles of the leading market players, including GE HealthCare, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Bayer AG and Becton, Dickinson and Co. (BD)


Companies Mentioned

Agilent Technologies Inc.
Altona Diagnostics Gmbh
Analytik Jena Gmbh+Co. Kg.
Bayer Ag
Bd
Bio-rad Laboratories Inc.
Danaher Corp.
F. Hoffmann-la Roche Ltd.
Ge Healthcare
Merck Kgaa
Promega Corp.
Qiagen
Revvity
Siemens Healthineers Ag
Thermo Fisher Scientific Inc.

Table of Contents

192 Pages
Chapter 1 Executive Summary
Market Outlook
Scope of the Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion
Chapter 2 Market Overview
Overview
Forces Driving Industry Growth
Porter's Five Forces Analysis
Potential for New Entrants (Moderate to High)
Bargaining Power of Suppliers (Moderate)
Bargaining Power of Buyers (Moderate)
Threat of Substitutes (Low to Moderate)
Industry Competition (High)
Macroeconomic Factors Analysis
Demand for Theranostics
Image-based Invasive and Noninvasive Procedures
Prevalence of Chronic Diseases and Rising Investments
Drug Discovery and Other R&D Activities
Development of Multifunctional Reagent Capabilities
Replacement of Toxic, Hazardous Detection Reagents with Safer Reagents
VC Investment
Impact of U.S. Tariff
Chapter 3 Market Dynamics
Overview
Market Drivers
Increasing Investments in R&D
Growing Prevalence of Chronic Diseases
Rising Adoption of Theranostics and Personalized Medicine
Replacement of Toxic Reagents with Safer Alternatives
Market Restraints
High Development and Commercialization Costs
Regulatory and Reimbursement Challenges
Market Opportunities
Integration of AI in Biologics R&D and Medical Imaging Reagents
Emergence of Multifunctional Imaging Reagents
Market Challenges
Safety Concerns
Short Shelf Life and Stability Issues
Chapter 4 Regulatory Landscape
Regulatory Approval Process, by Select Country/Region
U.S.
European Union
Asia-Pacific
Chapter 5 Emerging Technologies and Developments
Key Takeaways
Nanoparticles
Next-Generation Imaging Reagents for Single-Cell and Proteomic Applications
AI and ML in Biological and Medical Imaging Reagents
Innovative Lateral Flow Assays Enhanced by NIR Technology
Fluorochromes and Hybrid Targeting Platforms
Emerging Radiotracers Enhancing Diagnostic Accuracy in Oncology
Patent Analysis
Key Findings
Chapter 6 Market Segment Analysis
Segmentation Breakdown
Market Analysis by Product Type
Key Takeaways
Contrast Reagents
Radioactive Reagents
Optical Reagents
Market Analysis by Modality
Key Takeaways
Optical Imaging Reagents
X-ray/CT Reagents
Nuclear Imaging Reagents
MRI Imaging Reagents
Multimodal Imaging Reagents
Ultrasound Imaging Reagents
Market Analysis by Technology
Key Takeaways
Quantum Dots
Radiopharmaceuticals
Fluorescent Proteins
Fluorescent Dyes and Probes
Nanoparticles
Market Analysis by Application
Key Takeaways
In Vivo Imaging Reagents
In Vitro Imaging Reagents
Market Analysis by End Use
Key Takeaways
Diagnostics
R&D
Geographic Breakdown
Market Analysis by Region
Key Takeaways
North America
Europe
Asia-Pacific
South America
Middle East and Africa
Chapter 7 Competitive Intelligence
Key Takeaways
Global Market Shares of Leading Companies
Key Developments and Strategies
Partnerships and Collaborations
Acquisitions
Business Expansions
Product Launches and FDA Approvals
Chapter 8 Sustainability in Biological and Medical Imaging Reagents Market: ESG Perspective
Introduction to ESG
Steps Toward Sustainable Use of Biologics and Medical Imaging Reagents
Major Manufacturers: ESG Efforts
ESG Risk Ratings
Concluding Remarks from BCC
Chapter 9 Appendix
Methodology
Abbreviations
Sources
Company Profiles
AGILENT TECHNOLOGIES INC.
ALTONA DIAGNOSTICS GMBH
ANALYTIK JENA GMBH+CO. KG.
BAYER AG
BD
BIO-RAD LABORATORIES INC.
DANAHER CORP.
F. HOFFMANN-LA ROCHE LTD.
GE HEALTHCARE
MERCK KGAA
PROMEGA CORP.
QIAGEN
REVVITY
SIEMENS HEALTHINEERS AG
THERMO FISHER SCIENTIFIC INC.
Few Emerging Start-ups/Market Disruptors
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.